Related Experiment Videos
[Arguments for deciding to change treatment in benign prostatic hyperplasia]
1Clinique Saint-Grégoire, 18, rue Groison, 37100 Tours, France. jc.baron@wanadoo.fr
Annales D'Urologie
|January 18, 2005
Summary
Treatment changes for benign prostatic hyperplasia (BPH) lower urinary tract symptoms (LUTS) are driven by efficacy and side effects. Surgery is most effective, while medications offer alternatives with varying results and manageable side effects.
Area of Science:
- Urology
- Pharmacology
Context:
- Benign prostatic hyperplasia (BPH) is a common condition causing lower urinary tract symptoms (LUTS).
- Treatment decisions for LUTS/BPH are influenced by therapeutic efficacy, side effect profiles, and potential complications.
Purpose:
- To review the efficacy and side effect profiles of various treatments for LUTS/BPH.
- To guide clinical decision-making regarding treatment adjustments or surgical intervention.
Summary:
- Surgery demonstrates superior efficacy compared to medical treatments for LUTS/BPH.
- Alphablockers are the most active medical treatment, followed by 5-alpha-reductase inhibitors (more effective in large prostates) and phytotherapy (slight activity).
- Drug combinations are under investigation, potentially serving as alternatives to surgery in cases of single-agent therapy failure. Side effects are generally low and treatment-dependent, with orthostatic hypotension for alphablockers and sexual dysfunction for 5-alpha-reductase inhibitors.
Impact:
- Understanding treatment efficacy and side effects aids in optimizing patient management for LUTS/BPH.
- Identifying when to switch medications or opt for surgery is crucial for preventing complications and improving patient outcomes.
- Further research into drug combinations may offer new therapeutic avenues for managing LUTS/BPH.